Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 04 Nov 2024

Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Peikai Ding
Shengbin Pei
Zheng Qu
Yazhe Yang
Qiang Liu
Xiangyi Kong
Zhongzhao Wang
Jing Wang
Yi Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489444

2,403 views

Original Research

Published on 04 Nov 2024

Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma

in Cancer Immunity and Immunotherapy

Shuping Wu
Yu Liu
Yu Zeng
Xianhui Ruan
Mei Tao
Wenrong Lin
Chang Liu
Hongbin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463258

1,740 views

Original Research

Published on 04 Nov 2024

Identification of novel markers for neuroblastoma immunoclustering using machine learning

in Cancer Immunity and Immunotherapy

Longguo Zhang
Huixin Li
Fangyan Sun
Qiuping Wu
Leigang Jin
Aimin Xu
Jiarui Chen
Ranyao Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446273

1,508 views

Original Research

Published on 04 Nov 2024

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model

in Cancer Immunity and Immunotherapy

Alexis R. Steinmetz
Morgan Pierce
Alberto Martini
Come Tholomier
Ganiraju Manyam
Yan Chen
Akshay Sood
Jonathan J. Duplisea
Burles A. Johnson
Bogdan A. Czerniak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387229

2,616 views

Review

Published on 04 Nov 2024

Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis

in Cancer Immunity and Immunotherapy

Tiantian Yang
Wanru Luo
Jie Yu
Huiping Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481296

1,802 views

Mini Review

Published on 04 Nov 2024

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

in Cancer Immunity and Immunotherapy

Lin Zhou
Shuhui Yang
Youtao Li
Cheng Xue
Renping Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448728

1,825 views
1 citation

Original Research

Published on 04 Nov 2024

Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study

in Cancer Immunity and Immunotherapy

Xue-Mei You
Fei-Chen Lu
Fan-Rong Li
Feng-Juan Zhao
Rong-Rui Huo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463655

1,087 views

Original Research

Published on 01 Nov 2024

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

in Cancer Immunity and Immunotherapy

Weijie Wu
Zhenyun Yang
Hao Zou
Teng Long
Zhongguo Zhou
Yaojun Zhang
Minshan Chen
Dandan Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474456

1,208 views
1 citation

Original Research

Published on 01 Nov 2024

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy

in Cancer Immunity and Immunotherapy

Xiaoli Xia
Yixin Wang
Minghui Wang
Jian Lin
Ruiheng Wang
Shufeng Xie
Yaoyifu Yu
Jinlan Long
Zixuan Huang
Huajian Xian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451796

1,376 views

Review

Published on 01 Nov 2024

Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives

in Cancer Immunity and Immunotherapy

Jun Liu
Jingjian Peng
Jian Jiang
Yanhui Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476436

2,568 views

Review

Published on 01 Nov 2024

Macrophages in tumor cell migration and metastasis

in Cancer Immunity and Immunotherapy

Madeline Friedman-DeLuca
George S. Karagiannis
John S. Condeelis
Maja H. Oktay
David Entenberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494462

2,570 views
1 citation

Review

Published on 01 Nov 2024

Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy

in Cancer Immunity and Immunotherapy

Yu Gong
Desheng Gong
Sinian Liu
Xiangjin Gong
Jingwen Xiong
Jinghan Zhang
Lai Jiang
Jie Liu
Lin Zhu
Huiyang Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480572

1,476 views

Original Research

Published on 01 Nov 2024

Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancer

in Cancer Immunity and Immunotherapy

Jingjing Li
Qingqing Chen
Zhengcao Liu
Yingying Xu
Shengjun Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459206

705 views

Review

Published on 01 Nov 2024

Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: mechanisms, clinical applications, and future directions

in Cancer Immunity and Immunotherapy

Yujun Tong
Xiaobing Fan
Huan Liu
Tiantian Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495675

3,624 views
3 citations

Systematic Review

Published on 01 Nov 2024

Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Dandan Song
Shufu Hou
Ning Ma
Bing Yan
Jing Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485303

1,827 views

Original Research

Published on 01 Nov 2024

Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion

in Cancer Immunity and Immunotherapy

Zhixiong Su
Yaqi Zhong
Yufang He
Lijie You
Fuli Xin
Lei Wang
Zhihua Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469827

2,321 views
1 citation

Navigation group

Articles

Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer

Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma

Identification of novel markers for neuroblastoma immunoclustering using machine learning

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model

Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy

Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives

Macrophages in tumor cell migration and metastasis

Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy

Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancer

Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: mechanisms, clinical applications, and future directions

Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis

Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion